26.04.2017 • NewsDede WillamsSinochemDSM

DSM Sinochem Pharmaceuticals to Expand 7-ADCA Plant

(c) www.facebook.com/dsm.sinochem
(c) www.facebook.com/dsm.sinochem

Singapore-based DSM Sinochem Pharmaceuticals (DSP), a joint venture of Dutch chemicals and life sciences group DSM of the Netherlands and China’s Sinochem, is expanding production capacity at its plant in Delft , the Netherlands, up to the end of 2017 to meet growing demand for sustainably produced 7-ADCA, the key intermediate for cephalosporin active pharmaceutical ingredients (APIs). Other APIs produced at Delft include cephalexin, cefadroxil and cefradine.

The Dutch-Chinese company said the expansion builds on its commitment to producing antibiotics sustainably in the fight against antimicrobial resistance (AMR). It identifies irresponsible manufacturing as one of the key causes of resistance, due to the uncontrolled release of antibiotics into the environment.  In particular, it notes, waterways downstream of production facilities may contain significant concentrations of antimicrobial activity and risk becoming breeding grounds for resistance.

Upgrade plans at Delft include a new fermenter, which DSP said will use leading-edge technology that is energy efficient as well as environmentally friendly.  By its own account, it is the only remaining producer of 7-ADCA in the western hemisphere, in In the early 2000s having revolutionized the industry by introducing a new breakthrough process for sustainable high-quality production.

As “a leader in the sustainable production of β-lactam antibiotics,“ and one of 13 pharmaceutical industry signatories of the UN’S Industry Roadmap for Progress on Combating AMR, the company boasts of having implemented the cleanest production technology available and installed dedicated wastewater treatment plants. DSP said it also collaborates with industry partners, public and private stakeholders, associations, health professionals and regulators to clean up the supply chains.

 

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.